What is the 13F Pro Quality Score for BDMD?

13F Pro ranks Baird Medical Investment Holdings Ltd (BDMD) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View BDMD's current score at https://13fpro.ai/company/BDMD (free sign-up required for the full ranking).

Which hedge funds own the most BDMD stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of BDMD include Sculptor Capital, Clear Street Group, ARISTEIA CAPITAL, L.L.C.. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/BDMD as soon as new 13F filings post.

Where does 13F Pro source BDMD data?

All Baird Medical Investment Holdings Ltd fundamentals and ownership data come directly from SEC EDGAR. Baird Medical Investment Holdings Ltd files with the SEC under CIK 1982444. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is BDMD in?

Baird Medical Investment Holdings Ltd (BDMD) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is BDMD research updated on 13F Pro?

BDMD's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Baird Medical Investment Holdings Ltd(BDMD)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1982444 BDMD stock profile & AI dashboard →

13F Pro Quality Score

26.6/100

Rank #2,610 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why BDMD Scores 27/100

exact factor attribution · 2026-09-11

BDMD's composite is held back by profitability and revenue growth. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

+0.8 pts

58th pct

Institutional flow

-0.8 pts

33th pct

Earnings growth

-1.0 pts

30th pct

Shareholder dilution

-2.2 pts

7th pct

Scale

-3.0 pts

30th pct

Free cash flow

-3.6 pts

26th pct

Capital efficiency

-3.9 pts

11th pct

Revenue growth

-4.0 pts

30th pct

Profitability

-5.6 pts

13th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

BDMD Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Baird Medical Investment Holdings Ltd (BDMD), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BDMD at 26.6/100 on a 32-signal composite quality model, placing it at rank #2,610 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), Baird Medical Investment Holdings Ltd reports quarterly revenue of $22.5M, net income of $-27.3M, free cash flow of $-1.4M. Top institutional holders of BDMD by reported 13-F value include Sculptor Capital, Clear Street Group, ARISTEIA CAPITAL, L.L.C., based on the most recent SEC filings. BDMD trades on the Nasdaq exchange and files with the SEC under CIK 1982444. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BDMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Baird Medical Investment Holdings Ltd directly from SEC EDGAR.

Revenue

FY 2025

$22.5M

Net Income

FY 2025

$-27.3M

Free Cash Flow

FY 2025

$-1.4M

ROIC

FY 2025

-60.0%

D/E Ratio

FY 2025

0.36

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-39.2% YoY

$22.5MFY 2025

FY22 $35.1MFY23 $31.5MFY24 $37.0MFY25 $22.5M

Net Income

-319.0% YoY

$-27.3MFY 2025

FY22 —FY23 $10.5MFY24 $12.5MFY25 $-27.3M

Operating Income

-267.4% YoY

$-25.6MFY 2025

FY22 $13.6MFY23 $11.9MFY24 $15.3MFY25 $-25.6M

EPS (Diluted)

-271.9% YoY

$-0.98FY 2025

FY22 $0.49FY23 $0.51FY24 $0.57FY25 $-0.98

Total Assets

-10.6% YoY

$69.7MFY 2025

FY22 —FY23 $56.7MFY24 $78.0MFY25 $69.7M

Total Debt

+113.6% YoY

$11.4MFY 2025

FY22 —FY23 $2.4MFY24 $5.3MFY25 $11.4M

Op. Cash Flow

+78.7% YoY

$-1.3MFY 2025

FY22 $486.0KFY23 $-1.0MFY24 $-6.3MFY25 $-1.3M

Free Cash Flow

+84.9% YoY

$-1.4MFY 2025

FY22 $-5.4MFY23 $-3.7MFY24 $-9.2MFY25 $-1.4M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	$22.5M -39.2%	$37.0M +17.7%	$31.5M -10.4%	$35.1M	—
Net Income	$-27.3M -319.0%	$12.5M +18.1%	$10.5M	—	—
Operating Income	$-25.6M -267.4%	$15.3M +29.1%	$11.9M -13.0%	$13.6M	—
EPS (Diluted)	$-0.98 -271.9%	$0.57 +11.8%	$0.51 +4.1%	$0.49	—
Total Assets	$69.7M -10.6%	$78.0M +37.5%	$56.7M	—	—
Total Debt	$11.4M +113.6%	$5.3M +118.8%	$2.4M	—	—
Operating Cash Flow	$-1.3M +78.7%	$-6.3M -519.0%	$-1.0M -309.9%	$486.0K	—
Free Cash Flow	$-1.4M +84.9%	$-9.2M -150.6%	$-3.7M +32.5%	$-5.4M	—

Get alerted when BDMD's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Baird Medical Investment Holdings Ltd including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of BDMD

Sculptor Capital LP
$32.5K700,000 sh
Clear Street Group Inc.
$31.3K775,488 sh
ARISTEIA CAPITAL, L.L.C.
$26.5K570,992 sh
Calamos Advisors LLC
$24.5K500,000 sh
LINDEN ADVISORS LP
$21.3K435,179 sh
Kepos Capital LP
$17.0K416,479 sh
ADAGE CAPITAL PARTNERS GP, L.L.C.
$15.1K375,000 sh
MILLENNIUM MANAGEMENT LLC
$10.8K269,164 sh
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP
$10.1K250,000 sh
GOLDMAN SACHS GROUP INC
$8.9K220,004 sh

Fund	Value	Shares
Sculptor Capital LP	$32.5K	700,000
Clear Street Group Inc.	$31.3K	775,488
ARISTEIA CAPITAL, L.L.C.	$26.5K	570,992
Calamos Advisors LLC	$24.5K	500,000
LINDEN ADVISORS LP	$21.3K	435,179
Kepos Capital LP	$17.0K	416,479
ADAGE CAPITAL PARTNERS GP, L.L.C.	$15.1K	375,000
MILLENNIUM MANAGEMENT LLC	$10.8K	269,164
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP	$10.1K	250,000
GOLDMAN SACHS GROUP INC	$8.9K	220,004

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put BDMD on your watchlist

Track score changes the day Baird Medical Investment Holdings Ltd files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is BDMD a good stock to buy?

13F Pro's AI-powered analysis of Baird Medical Investment Holdings Ltd (BDMD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BDMD are available on the BDMD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. BDMD is classified as a small company.

Which hedge funds own BDMD?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BDMD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Baird Medical Investment Holdings Ltd's investment landscape.